SCHEMBL7067375

SCHEMBL7067375

CCCCN1C(=O)NC(=O)C(=C2SCCCS2)C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.38
MAPT P10636 6/20 0.38
TDP1 Q9NUW8 5/20 0.38
HPGD P15428 3/20 0.38
NPSR1 Q6W5P4 2/20 0.38
KDM4E B2RXH2 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.35
L3MBTL1 Q9Y468 5/20 0.34
KMT2A Q03164 5/20 0.34
MEN1 O00255 4/20 0.34
MAPK1 P28482 3/20 0.34
RAB9A P51151 3/20 0.34
NPC1 O15118 2/20 0.34
HTT P42858 2/20 0.34
POLB P06746 2/20 0.34
USP2 O75604 2/20 0.34
CNR1 P21554 3/20 0.33
GAA P10253 2/20 0.32
LMNA P02545 2/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5634261 0.82 ALDH1A1 (0.38) ALDH1A1MAPTTDP1HPGDNPSR1
SCHEMBL2728279 0.74 HPGD (0.49) ALDH1A1MAPTTDP1HPGDNPSR1
SCHEMBL5633146 0.72 ALDH1A1 (0.34) ALDH1A1MAPTTDP1SMN1; SMN2L3MBTL1
SCHEMBL5633394 0.72 ALDH1A1 (0.31) ALDH1A1MAPTTDP1SMN1; SMN2L3MBTL1
SCHEMBL5634017 0.71 AGTR1 (0.36) ALDH1A1MAPTTDP1HPGDNPSR1
SCHEMBL5632839 0.71 ALDH1A1 (0.36) ALDH1A1MAPTTDP1HPGDNPSR1
SCHEMBL1101454 0.71 ALDH1A1 (0.47) ALDH1A1MAPTTDP1HPGDNPSR1
SCHEMBL11499891 0.69 MGLL (0.48) ALDH1A1MAPTTDP1HPGDNPSR1
SCHEMBL5634864 0.69 TDP1 (0.50) ALDH1A1MAPTTDP1HPGDNPSR1
SCHEMBL5632868 0.69 CRHBP (0.34) ALDH1A1SMN1; SMN2L3MBTL1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4608810-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE TO TREAT HYPOPARATHYROIDISM AND OSTEOPOROSIS Septerna, Inc. (US) 2025-09-03 EP disclosed
WO-2024091498-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF USE TO TREAT HYPOPARATHYROIDISM AND OSTEOPOROSIS SEPTERNA, INC. (US) 2024-05-02 WO disclosed
WO-2003037262-A2 NOVEL ANIT-INFECTIVES SMITHKLINE BEECHAM CORPORATION (US) 2003-05-08 WO disclosed